USPTO serial 79211775
ALOFISEL
Reviewed by CopyMark Law Group
Reg. 5466721Status 709
- Filing date
- Status date
- Registration date
- May 15, 2018
- Examiner
- RYDLAND, STEPHANIE DIANA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALOFISEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Tres Cantos (Madrid), ES
Tres Cantos (Madrid), ES
Takeda Pharmaceuticals International AG
CH
Other trademarks owned by Takeda Pharmaceuticals International AG
Tres Cantos (Madrid), ES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karl M. Zielaznicki, Esq.
Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP875 Third Avenuec/o IP Services NYCNew York, NY 10022Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; pharmaceutical and diagnostic preparations for medical purposes for the treatment of fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; cellular, biological or bacteriological preparations for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients; live cellular tissue implants or engineered live cellular tissue for medical purposes, namely, for the treatment of fistulas, fistulas in Crohn's disease patients, complex perianal fistulas and complex perianal fistulas in Crohn's disease patients | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TIGENIX, S.A.U.
- Other trademarks owned by TIGENIX, S.A.U.
- Other trademarks owned by Takeda Pharmaceuticals International AG
- Other trademarks owned by TIGENIX, S.A.U.
- Other trademarks in Class 005
- Similar marks named ALOFISEL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 26, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 26, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 28, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 29, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 28, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 15, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 23, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 2, 2020 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Jul 1, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 1, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 1, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 1, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 1, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 15, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 24, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 24, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 15, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 15, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 9, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 27, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 27, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 21, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 7, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 22, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 15, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 15, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 15, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 15, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 10, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 10, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 4, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 18, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 18, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 12, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 11, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 11, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |